Amylyx Pharmaceuticals AMLX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$7.85M (12 inflow days, 8 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 39.3% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 12.05% to 10.22% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +3,217,592 | 15.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,540,922 | 8.1% |
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +1,486,482 | 2.5% |
| Artal Group S.A. | VC/PE Fund | 2026/Q3 | +1,000,000 | 1.9% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +979,843 | 3.1% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +853,287 | 3.9% |
| Deutsche Asset & Wealth Management | Mutual Fund | 2026/Q3 | +515,778 | 0.8% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +435,666 | 0.6% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +324,916 | 2.1% |
| Universal Investment GmbH | Mutual Fund | 2026/Q3 | +247,076 | 0.2% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +174,872 | 0.2% |
| TD Asset Management | Mutual Fund | 2026/Q3 | +165,030 | 0.1% |
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +1,667,888 | 1.4% |
| Alyeska Investment Group, L.P. | Hedge Fund | 2026/Q3 | +1,053,015 | 0.8% |
| Morgan Stanley | Public Company | 2026/Q3 | +950,246 | 2.4% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | James Frates | Chief Financial Officer | Derivative Exercise and Sale | -40,000 | $30.97 | 227,434 |
| 8 Nov 2026 | Joshua Cohen | Co-Chief Executive Officer | Automatic Disposition | -100,000 | $30.11 | 3,053,336 |
| 8 Nov 2026 | Justin Klee | Co-Chief Executive Officer | Automatic Disposition | -100,000 | $30.11 | 3,053,269 |
| 4 Oct 2026 | George Milne | Independent Chairperson | Automatic Disposition | -30,000 | $27.70 | 782,881 |
| 9 Sep 2026 | James Frates | Chief Financial Officer | Private Disposition | -1,042 | $33.23 | 227,434 |
| 9 Sep 2026 | James Frates | Chief Financial Officer | Open Market Disposition | -9,768 | $32.27 | 227,434 |
| 9 Sep 2026 | Camille Bedrosian | Chief Medical Officer | Private Disposition | -2,081 | $33.09 | 101,592 |
| 9 Sep 2026 | Camille Bedrosian | Chief Medical Officer | Open Market Disposition | -7,947 | $32.21 | 101,592 |
| 9 Sep 2026 | Joshua Cohen | Co-Chief Executive Officer | Private Disposition | -919 | $33.15 | 3,153,336 |
| 9 Sep 2026 | Joshua Cohen | Co-Chief Executive Officer | Open Market Disposition | -29,545 | $32.16 | 3,153,336 |
| 9 Sep 2026 | Justin Klee | Co-Chief Executive Officer | Private Disposition | -1,439 | $33.16 | 3,153,269 |
| 9 Sep 2026 | Justin Klee | Co-Chief Executive Officer | Open Market Disposition | -29,025 | $32.13 | 3,153,269 |
| 9 Sep 2026 | Gina Mazzariello | Chief Legal Officer & General Counsel | Private Disposition | -11 | $33.34 | 45,373 |
| 9 Sep 2026 | Gina Mazzariello | Chief Legal Officer & General Counsel | Open Market Disposition | -9,525 | $32.46 | 45,373 |
| 30 Aug 2026 | Karen Firestone | Independent Director | Derivative Exercise and Retained | +50,000 | $5.05 | 116,900 |
| 17 Aug 2026 | James Frates | Chief Financial Officer | Other Acquisition | +22,807 | – | 238,244 |
| 17 Aug 2026 | Camille Bedrosian | Chief Medical Officer | Other Acquisition | +22,807 | – | 111,620 |
| 17 Aug 2026 | Joshua Cohen | Co-Chief Executive Officer | Other Acquisition | +60,039 | – | 3,183,800 |
| 17 Aug 2026 | Justin Klee | Co-Chief Executive Officer | Other Acquisition | +60,039 | – | 3,183,733 |
| 17 Aug 2026 | Gina Mazzariello | Chief Legal Officer & General Counsel | Other Acquisition | +21,284 | – | 54,909 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 12,823,384 | 10.2% | 10.5 |
| 15 Oct 2026 | 13,249,442 | 10.6% | 9.9 |
| 30 Sep 2026 | 12,666,971 | 10.1% | 9.2 |
| 15 Sep 2026 | 13,512,753 | 12.1% | 8.6 |
| 31 Aug 2026 | 12,737,201 | 11.4% | 2.4 |
| 14 Aug 2026 | 13,425,106 | 12.0% | 7.1 |
No comments yet — be the first to weigh in on AMLX.
Sign in to join the discussion.